Edwards Lifesciences had 17 patents in internet of things during Q4 2023. The abstracts describe sensor implant devices for monitoring fluid flow and heart valve function, as well as methods for predicting hypotensive events during anesthesia administration. The devices include shunt bodies with sensor devices and antennas, while the methods involve extracting waveform features to determine post-induction scores and assessing heart valve dysfunction based on blood flow velocity profiles. GlobalData’s report on Edwards Lifesciences gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Edwards Lifesciences grant share with internet of things as a theme is 5% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Implant devices with shunt channel sensors (Patent ID: US20230389811A1)
See Also:
The patent filed by Edwards Lifesciences Corp. describes a sensor implant device that includes a shunt body forming a fluid conduit with a first anchor structure at one end and a sensor device coupled to the anchor structure. The sensor device has a sensor transducer that projects into a channel area defined by the radial boundary around the axis of the fluid conduit. The device can be deployed with the sensor transducer facing a specific direction to optimize sensing capabilities.
The sensor implant device also includes multiple anchor structures and sensor devices for enhanced functionality. The anchor structures are designed to extend radially or axially from the fluid conduit, allowing the sensor transducers to project into the channel area effectively. The configuration of the sensor implant device can be adjusted between a delivery configuration, where the sensor transducers are within the fluid conduit, and a deployed configuration, where they project radially away from the conduit. This design enables accurate sensing in medical applications where monitoring fluid flow or pressure is crucial.
To know more about GlobalData’s detailed insights on Edwards Lifesciences, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
